WCN24-355 INDIVIDUAL BETA BLOCKER AGENTS AND MORTALITY IN CHRONIC HEMODIALYSIS PATIENTS: AN INTERNATIONAL COHORT STUDY

WCN24-355 INDIVIDUAL BETA BLOCKER AGENTS AND MORTALITY IN CHRONIC HEMODIALYSIS PATIENTS: AN INTERNATIONAL COHORT STUDY

Saved in:

Bibliographic Details
Main Authors:	Gregory Hundemer, Corey Toye, Manish Sood, Ranjeeta Mallick, Ayub Akbari
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924007344
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1978 COMPARISON OF SPOT AND 24-HOUR URINE OSMOLALITY MEASUREMENTS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
by: Ayub Akbari, et al.
Published: (2024-04-01)

Сardioprotective agents with biaromatic structure. Part 6. Beta blockers
by: G. V. Mokrov
Published: (2023-11-01)

WCN24-2081 ATYPICAL MANIFESTATION OF TUBERCULOSIS IN HEMODIALYSIS
by: Veronica Escurra, et al.
Published: (2024-04-01)

WCN24-1937 RENOPROTECTIVE EFFECT OF 3RD GENERATION CALCIUM CHANNEL BLOCKERS
by: Joaquín Martinez Serventi, et al.
Published: (2024-04-01)

WCN25-2199 Is there a role for substituting non-vasodilatory beta-blockers in managing hypertension in CKD ?
by: Sayali Kondkar, et al.
Published: (2025-02-01)

WCN24-2581 TRANSLUMBAR CATHETER, AN UNCONVENTIONAL OPTION FOR HEMODIALYSIS
by: Cristian Josue Ramos Mares, et al.
Published: (2024-04-01)

WCN24-707 QUALITY OF LIFE IN HEMODIALYSIS PATIENTS IN BOLIVIA
by: Silvestre Arze, et al.
Published: (2024-04-01)

WCN24-2230 ELECTROCARDIOGRAPHIC FINDINGS IN CHRONIC HEMODIALYSIS PATIENTS
by: Celso Felipe Mazariegos Campos, et al.
Published: (2024-04-01)

WCN24-1422 MALNUTRITION IN HEMODIALYSIS PATIENTS WITH OR WITHOUT DIABETES
by: Valeria Aicardi, et al.
Published: (2024-04-01)

Beta blockers and their combinations in the management of hypertension
by: J.A. Ker
Published: (2012-10-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

WCN24-2134 TG/HDL-C ratio as mortality predictor in chronic hemodialysis patients
by: Yessica Lopez Cabrera, et al.
Published: (2024-04-01)

WCN24-981 THE NUTRITIONAL RISK INDEX FOR JAPANESE HEMODIALYSIS IS ASSOCIATED WITH FRAILTY IN HEMODIALYSIS PATIENTS
by: Masaki Hara, et al.
Published: (2024-04-01)

WCN24-714 AMBULATE DURING HEMODIALYSIS THERAPY – SHARING EXPERIENCE
by: Cinthia Vieira, et al.
Published: (2024-04-01)

WCN24-2417 SYMPTOM CLUSTERS IN HEMODIALYSIS PATIENTS AND QUALITY OF LIFE
by: Konstantin Vishnevskii, et al.
Published: (2024-04-01)

WCN24-2115 Inflammatory Determinants and Associated Morbidity in Hemodialysis Patients
by: Roxana Villanueva Macedo, et al.
Published: (2024-04-01)

Beta-blockers. What about goes unsaid?
by: I. A. Latfullin
Published: (2008-10-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

Pharmacoepidemiological Beta-blockers consumer research in Ukraine
by: O. Ya. Mishchenko, et al.
Published: (2012-12-01)

Beta-blockers in Cardiovascular Therapy: A Review
by: Camelia C. Diaconu, et al.
Published: (2019-10-01)

WCN24-133 ARTERIOVENOUS FISTULA DYSFUNCTION IN PATIENTS ON MAINTENANCE HEMODIALYSIS IN FOUR HEMODIALYSIS CENTERS IN CAMEROON
by: RONALD GOBINA, et al.
Published: (2024-04-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

WCN24-713 ONLINE HEMODIAFILTRATION IS MORE EFFICIENT THAN HIGH FLOW HEMODIALYSIS IN THE CLEARANCE OF MEDIUM WEIGHT MOLECULES RENDERING AS BETA 2 MICROGLOBULIN
by: Ricardo Silvariño, et al.
Published: (2024-04-01)

Spectrophotometric Study of ?-Irradiated PM-355
by: Baghdad Science Journal
Published: (2009-09-01)

WCN24-2193 PREVALENCE OF MUSCULAR ATROPHY IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Myrian Cipres, et al.
Published: (2024-04-01)

WCN24-1129 CKD-MBD Status in Maintenance Hemodialysis Patients in Bangladesh
by: Farnaz Nobi, et al.
Published: (2024-04-01)

WCN24-1821 VASCULAR ACCES – RELATED MORBIDITY IN HEMODIALYSIS PATIENTS IN URUGUAY
by: Leonella Luzardo, et al.
Published: (2024-04-01)

WCN24-711 ANEMIA MANAGEMENT IN CHRONIC HEMODIALYSIS PATIENTS AT HIGH ALTITUDE
by: Silvestre Arze, et al.
Published: (2024-04-01)

WCN24-2403 Is home hemodialysis feasible for Colombia? Cost-utility perspective
by: Camilo Gonzalez, et al.
Published: (2024-04-01)

WCN24-2428 ECHOCARDIOGRAPHIC ANOMALIES AMONG CHRONIC HEMODIALYSIS PATIENTS IN DIOURBEL
by: Ibrahima Lyra SARR, et al.
Published: (2024-04-01)

WCN24-424 Current status, utilization and cost of hemodialysis services in Ghana
by: Elliot Koranteng Tannor, et al.
Published: (2024-04-01)

WCN24-618 BENEFITS OF ONLINE HEMODIAFILTRATION VERSUS HIGH FLUX HEMODIALYSIS
by: Vasilije Tomanoski, et al.
Published: (2024-04-01)

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose
by: Varun Roperia MD, et al.
Published: (2025-07-01)

WCN24-475 GENDER DISPARITY IN HEMODIALYSIS PRACTICES, PREVALENCE AND MORTALITY: A NATIONWIDE CROSS-SECTIONAL STUDY
by: Mythri Shankar, et al.
Published: (2024-04-01)

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
by: Hirofumi Tomiyama, et al.
Published: (2014-01-01)

Local Application of Beta-Blockers for Capillary Hemangioma of Eyelid
by: Manpreet Singh, et al.
Published: (2017-10-01)

Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers
by: Michael Liang, et al.
Published: (2009-01-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
by: A. A. Aleksandrov, et al.
Published: (2016-01-01)

Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol
by: N. L. Afanasyeva, et al.
Published: (2005-02-01)